NO931153L - Vannloeselige camptothecin-analoger fremgangsmaater og metoder - Google Patents
Vannloeselige camptothecin-analoger fremgangsmaater og metoderInfo
- Publication number
- NO931153L NO931153L NO93931153A NO931153A NO931153L NO 931153 L NO931153 L NO 931153L NO 93931153 A NO93931153 A NO 93931153A NO 931153 A NO931153 A NO 931153A NO 931153 L NO931153 L NO 931153L
- Authority
- NO
- Norway
- Prior art keywords
- methods
- procedures
- soluble camptothecin
- camptothecin analogs
- analogs
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
- C07D491/22—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains four or more hetero rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Public Health (AREA)
- General Chemical & Material Sciences (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Processing And Handling Of Plastics And Other Materials For Molding In General (AREA)
- Auxiliary Devices For And Details Of Packaging Control (AREA)
- Steroid Compounds (AREA)
- Fodder In General (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US58964390A | 1990-09-28 | 1990-09-28 | |
PCT/US1991/006888 WO1992005785A1 (en) | 1990-09-28 | 1991-09-23 | Water soluble camptothecin analogues, processes and methods |
Publications (2)
Publication Number | Publication Date |
---|---|
NO931153D0 NO931153D0 (no) | 1993-03-26 |
NO931153L true NO931153L (no) | 1993-03-26 |
Family
ID=24358879
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
NO93931153A NO931153L (no) | 1990-09-28 | 1993-03-26 | Vannloeselige camptothecin-analoger fremgangsmaater og metoder |
Country Status (25)
Country | Link |
---|---|
US (1) | US5734056A (de) |
EP (1) | EP0547165B1 (de) |
JP (1) | JP2848958B2 (de) |
CN (1) | CN1033509C (de) |
AT (1) | ATE186461T1 (de) |
AU (1) | AU664830B2 (de) |
CA (1) | CA2090967C (de) |
CZ (1) | CZ51593A3 (de) |
DE (1) | DE69131775T2 (de) |
DK (1) | DK0547165T3 (de) |
ES (1) | ES2137932T3 (de) |
FI (1) | FI931384A (de) |
GR (1) | GR3031823T3 (de) |
HK (1) | HK1012283A1 (de) |
HU (1) | HUT70024A (de) |
IE (1) | IE913402A1 (de) |
IL (1) | IL99571A (de) |
NO (1) | NO931153L (de) |
NZ (1) | NZ239947A (de) |
PT (1) | PT99109B (de) |
SI (1) | SI9111599A (de) |
SK (1) | SK283693B6 (de) |
WO (1) | WO1992005785A1 (de) |
YU (1) | YU159991A (de) |
ZA (1) | ZA917748B (de) |
Families Citing this family (57)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
AP9300587A0 (en) * | 1992-11-12 | 1995-05-05 | Glaxo Inc | Water soluble camptothecin derivatives. |
US5527913A (en) * | 1993-02-25 | 1996-06-18 | The Stehlin Foundation For Cancer Research | Methods for purifying camptothecin compounds |
US5880131A (en) * | 1993-10-20 | 1999-03-09 | Enzon, Inc. | High molecular weight polymer-based prodrugs |
US5447936A (en) * | 1993-12-22 | 1995-09-05 | Bionumerik Pharmaceuticals, Inc. | Lactone stable formulation of 10-hydroxy 7-ethyl camptothecin and methods for uses thereof |
GB9402934D0 (en) * | 1994-02-16 | 1994-04-06 | Erba Carlo Spa | Camptothecin derivatives and process for their preparation |
KR960029336A (ko) * | 1995-01-09 | 1996-08-17 | 김충환 | 캄토테신 유도체, 그의 제조 방법 및 이를 함유하는 항암제 |
US5726181A (en) * | 1995-06-05 | 1998-03-10 | Bionumerik Pharmaceuticals, Inc. | Formulations and compositions of poorly water soluble camptothecin derivatives |
JPH08333370A (ja) * | 1995-06-08 | 1996-12-17 | Kyorin Pharmaceut Co Ltd | 水に可溶な新規フルオロエチルカンプトテシン誘導体、及びその製造方法 |
AU7732996A (en) * | 1995-11-22 | 1997-06-11 | Research Triangle Institute | Camptothecin compounds with combined topoisomerase i inhibition and dna alkylation properties |
US6407118B1 (en) | 1996-01-30 | 2002-06-18 | The Stehlin Foundation For Cancer Research | Derivatives of camptothecin and methods of treating cancer using these derivatives |
US5731316A (en) | 1996-01-30 | 1998-03-24 | The Stehlin Foundation For Cancer Research | Derivatives of camptothecin and methods of treating cancer using these derivatives |
GB9601779D0 (en) * | 1996-01-30 | 1996-04-03 | Pharmacia Spa | 9, 10 Disubstituted camptothecin derivatives |
US6096336A (en) * | 1996-01-30 | 2000-08-01 | The Stehlin Foundation For Cancer Research | Liposomal prodrugs comprising derivatives of camptothecin and methods of treating cancer using these prodrugs |
US6043367A (en) * | 1998-09-30 | 2000-03-28 | Roffler; Steve | Proactive antitumor compounds |
US6228855B1 (en) | 1999-08-03 | 2001-05-08 | The Stehlin Foundation For Cancer Research | Aromatic esters of camptothecins and methods to treat cancers |
US6352996B1 (en) | 1999-08-03 | 2002-03-05 | The Stehlin Foundation For Cancer Research | Liposomal prodrugs comprising derivatives of camptothecin and methods of treating cancer using these prodrugs |
AU775373B2 (en) | 1999-10-01 | 2004-07-29 | Immunogen, Inc. | Compositions and methods for treating cancer using immunoconjugates and chemotherapeutic agents |
WO2004055020A1 (en) * | 2002-12-16 | 2004-07-01 | Council Of Scientific And Industrial Research | Process for the direct preparation of 5-alkoxy and 5-acyloxy analogues of campthothecins or mappicene ketones |
AU2003223109A1 (en) * | 2003-03-31 | 2004-10-25 | Council Of Scientific And Industrial Research | Process for preparing topotecan from 10-hydroxy-4-(s) camptothecin |
CA2523059A1 (en) * | 2003-05-12 | 2004-11-25 | Scinopharm Taiwan, Ltd. | Process for the preparation of 7-alkyl-10-hydroxy-20(s)-camptothecin |
CZ298934B6 (cs) * | 2003-08-26 | 2008-03-12 | Pliva- Lachema A.S. | Zpusob výroby 7-ethyl-10-hydroxykamptothecinu |
CZ299329B6 (cs) * | 2003-08-26 | 2008-06-18 | Pliva-Lachema A.S. | Zpusob výroby 7-ethyl-10-[ 4-(1-piperidino)-1-piperidino]karbonyloxykamptothecinu |
TWI333492B (en) * | 2003-11-12 | 2010-11-21 | Smithkline Beecham Cork Ltd | Crystalline topotecan hydrochloride product and preparation thereof |
CZ299593B6 (cs) * | 2003-12-16 | 2008-09-10 | Pliva-Lachema A. S. | Zpusob výroby 7-ethyl-10-hydroxykamptothecinu |
US20050267141A1 (en) | 2004-05-28 | 2005-12-01 | Phytogen Life Sciences Inc. | Process to prepare camptothecin derivatives |
US20050272757A1 (en) * | 2004-06-04 | 2005-12-08 | Phytogen Life Sciences Inc. | Process to prepare camptothecin derivatives and novel intermediate and compounds thereof |
WO2006016203A1 (en) * | 2004-08-09 | 2006-02-16 | Shilpa Medicare Limited | An improved process for the preparation of irinotecan hydrochloride trihydrate |
KR100848919B1 (ko) * | 2004-11-05 | 2008-07-29 | 주식회사 삼양사 | 10-히드록시캄토테신 화합물의 극성 비수성 용매에 대한용해도를 증가시키기 위한 약제학적 제형 |
US20060135546A1 (en) * | 2004-12-16 | 2006-06-22 | Jagadevappa Basavaraja | Methods for the purification of 20(S)- camptothecin |
KR20080035630A (ko) * | 2005-07-18 | 2008-04-23 | 바이파 사이언스 인코포레이티드 | 암의 치료 |
WO2007042799A1 (en) * | 2005-10-10 | 2007-04-19 | Cipla Limited | Novel crystalline forms |
US7547785B2 (en) | 2005-12-26 | 2009-06-16 | Dr. Reddy's Laboratories Limited | Process for preparing topotecan |
WO2007127839A2 (en) * | 2006-04-26 | 2007-11-08 | The Regents Of The University Of California | Compositions and methods for convection enhanced delivery of high molecular weight neurotherapeutics |
AR060635A1 (es) | 2006-04-27 | 2008-07-02 | Banyu Pharma Co Ltd | Derivados de 1,2-dihidro-3h-pirazolo[3,4-d]pirimidin-3-ona, composiciones farmaceuticas que los comprenden y su uso en el tratamiento del cancer |
US20100279327A1 (en) * | 2006-06-12 | 2010-11-04 | Bipar Sciences, Inc. | Method of treating diseases with parp inhibitors |
CA2655257A1 (en) * | 2006-06-12 | 2008-12-04 | Bipar Sciences, Inc. | Method of treating diseases with parp inhibitors |
US20080039485A1 (en) * | 2006-08-08 | 2008-02-14 | Targetgen Biotechnology Co., Ltd. | Low-dose-long-term pharmaceutical composition comprising camptothecin derivatives for the treatment of cancers |
JP2008081492A (ja) | 2006-08-31 | 2008-04-10 | Banyu Pharmaceut Co Ltd | オーロラa選択的阻害作用を有する新規アミノピリジン誘導体 |
EP2061479A4 (de) * | 2006-09-05 | 2010-08-04 | Bipar Sciences Inc | Fettsäuresynthesehemmung durch parp-hemmer und behandlungsverfahren damit |
US8143447B2 (en) * | 2006-09-05 | 2012-03-27 | Bipar Sciences, Inc. | Treatment of cancer |
US7977336B2 (en) | 2006-12-28 | 2011-07-12 | Banyu Pharmaceutical Co. Ltd | Aminopyrimidine derivatives as PLK1 inhibitors |
US7977483B2 (en) | 2007-04-11 | 2011-07-12 | Scinopharm Taiwan, Ltd. | Process for making topotecan |
EP2211854A4 (de) * | 2007-10-19 | 2011-01-12 | Bipar Sciences Inc | Verfahren und zusammensetzungen zur behandlung von krebs mit parp-inhibitoren vom benzopyrontyp |
JPWO2009054332A1 (ja) | 2007-10-23 | 2011-03-03 | 萬有製薬株式会社 | ピリドン置換ジヒドロピラゾロピリミジノン誘導体 |
JP2011503071A (ja) * | 2007-11-12 | 2011-01-27 | バイパー サイエンシズ,インコーポレイティド | Parp阻害剤単独又は抗腫瘍剤との組み合わせによる子宮がん及び卵巣がんの治療 |
KR20100102609A (ko) * | 2007-11-12 | 2010-09-24 | 바이파 사이언스 인코포레이티드 | Parp 억제제를 단독으로 사용하거나 항종양제와 병용하여 유방암을 치료하는 방법 |
ITMI20072268A1 (it) | 2007-12-04 | 2009-06-05 | Antibioticos Spa | Polimorfi cristallini di topotecan cloridrato con elevato grado di purezza e metodi per la loro preparazione |
WO2009073869A1 (en) * | 2007-12-07 | 2009-06-11 | Bipar Sciences, Inc. | Treatment of cancer with combinations of topoisomerase inhibitors and parp inhibitors |
CN101450949B (zh) * | 2007-12-07 | 2011-10-05 | 上海龙翔生物医药开发有限公司 | 一种10-羟基喜树碱的化学半合成工艺 |
ES2425621T3 (es) | 2008-05-29 | 2013-10-16 | Microbiopharm Japan Co., Ltd. | Métodos para producir derivados de camptotecina |
CA2750716A1 (en) | 2009-02-25 | 2010-09-02 | Msd K.K. | Pyrimidopyrimidoindazole derivative |
EP2403339B1 (de) | 2009-03-06 | 2017-01-18 | Merck Sharp & Dohme Corp. | Tumorkombinationstherapie mit einem akt-hemmer und anderen antumormitteln |
EP2654754B1 (de) | 2010-12-17 | 2016-12-21 | Novartis AG | Kombination zur behandlung von osteosarcoma, rhabdomyosarcoma und neuroblastoma |
EP2672969A4 (de) | 2011-02-01 | 2014-07-16 | Glaxosmithkline Intellectual Property Ltd | Kombination |
CN103145720B (zh) * | 2013-02-20 | 2015-09-30 | 上海北卡医药技术有限公司 | 一种10-羟基喜树碱的一水合物的制备方法 |
EP2881396A1 (de) * | 2013-12-03 | 2015-06-10 | Synbias Pharma AG | Verfahren zur Synthese von Irinotecan |
WO2023220641A2 (en) | 2022-05-11 | 2023-11-16 | Juno Therapeutics, Inc. | Methods and uses related to t cell therapy and production of same |
Family Cites Families (11)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4473692A (en) * | 1981-09-04 | 1984-09-25 | Kabushiki Kaisha Yakult Honsha | Camptothecin derivatives and process for preparing same |
JPS595188A (ja) * | 1982-06-30 | 1984-01-12 | Yakult Honsha Co Ltd | 10−ヒドロキシカンプトテシンの製造法 |
JPS5946284A (ja) * | 1982-09-10 | 1984-03-15 | Yakult Honsha Co Ltd | 11−ニトロカンプトテシン誘導体およびその製造法 |
US4894456A (en) * | 1987-03-31 | 1990-01-16 | Research Triangle Institute | Synthesis of camptothecin and analogs thereof |
US4981968A (en) * | 1987-03-31 | 1991-01-01 | Research Triangle Institute | Synthesis of camptothecin and analogs thereof |
US4943579A (en) * | 1987-10-06 | 1990-07-24 | The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services | Water soluble prodrugs of camptothecin |
US5004758A (en) * | 1987-12-01 | 1991-04-02 | Smithkline Beecham Corporation | Water soluble camptothecin analogs useful for inhibiting the growth of animal tumor cells |
JPH0615547B2 (ja) * | 1988-01-20 | 1994-03-02 | 株式会社ヤクルト本社 | 新規なカンプトテシン誘導体 |
GB9008605D0 (en) * | 1990-04-17 | 1990-06-13 | Smith Kline French Lab | Process |
HU213136B (en) * | 1990-08-14 | 1997-02-28 | Kyorin Seiyaku Kk | Process for producing fluoroethyl camptothecin derivatives and pharmaceutical compositions containing them |
US5352789A (en) * | 1993-02-25 | 1994-10-04 | The Stehlin Foundation For Cancer Research | Methods for purifying camptothecin compounds |
-
1991
- 1991-09-23 DK DK91918278T patent/DK0547165T3/da active
- 1991-09-23 ES ES91918278T patent/ES2137932T3/es not_active Expired - Lifetime
- 1991-09-23 SK SK259-93A patent/SK283693B6/sk not_active IP Right Cessation
- 1991-09-23 CA CA002090967A patent/CA2090967C/en not_active Expired - Lifetime
- 1991-09-23 CZ CS93515A patent/CZ51593A3/cs unknown
- 1991-09-23 EP EP91918278A patent/EP0547165B1/de not_active Expired - Lifetime
- 1991-09-23 DE DE69131775T patent/DE69131775T2/de not_active Expired - Lifetime
- 1991-09-23 AU AU87399/91A patent/AU664830B2/en not_active Expired
- 1991-09-23 HU HU9300878A patent/HUT70024A/hu unknown
- 1991-09-23 WO PCT/US1991/006888 patent/WO1992005785A1/en active IP Right Grant
- 1991-09-23 AT AT91918278T patent/ATE186461T1/de not_active IP Right Cessation
- 1991-09-23 JP JP3516992A patent/JP2848958B2/ja not_active Expired - Lifetime
- 1991-09-26 IL IL9957191A patent/IL99571A/xx not_active IP Right Cessation
- 1991-09-26 NZ NZ23994791A patent/NZ239947A/en not_active IP Right Cessation
- 1991-09-27 PT PT99109A patent/PT99109B/pt not_active IP Right Cessation
- 1991-09-27 ZA ZA917748A patent/ZA917748B/xx unknown
- 1991-09-27 IE IE340291A patent/IE913402A1/en not_active IP Right Cessation
- 1991-09-28 CN CN91110656A patent/CN1033509C/zh not_active Expired - Lifetime
- 1991-09-30 SI SI9111599A patent/SI9111599A/sl unknown
- 1991-09-30 YU YU159991A patent/YU159991A/sh unknown
-
1993
- 1993-03-26 FI FI931384A patent/FI931384A/fi not_active Application Discontinuation
- 1993-03-26 NO NO93931153A patent/NO931153L/no unknown
-
1995
- 1995-05-25 US US08/451,079 patent/US5734056A/en not_active Expired - Lifetime
-
1998
- 1998-12-16 HK HK98113607A patent/HK1012283A1/xx not_active IP Right Cessation
-
1999
- 1999-11-11 GR GR990402820T patent/GR3031823T3/el unknown
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
NO931153L (no) | Vannloeselige camptothecin-analoger fremgangsmaater og metoder | |
DK589985A (da) | Bicycliske heteroarylpiperazinderivater og fremgangsmaade til deres fremstilling | |
JPS5412381A (en) | N-alkylpiperidine derivative | |
GB2200367B (en) | Method of preparing genetically transformed cellular plant matter by micro- injection. | |
SE8105079L (sv) | Antibiotikum bmg162-af2 | |
JPS52286A (en) | Method of preparing 1-(3-phenylpropyl)-4-acylpiperazine derivatives | |
RO87707A (ro) | Procedeu pentru prepararea unor saruri de piridiniu | |
JPS51115987A (en) | Process for cultivating chlorella | |
JPS5297934A (en) | N#-arylsulfonyl-l-argininamides and their salts acceptable as medicine s | |
SE436137B (sv) | Forfarande for framstellning av proteasinhibitorer, benemnda procidiner, genom odling av den nya stammen atcc 31233, tillhorande slektet actinomadura | |
IT8223502A0 (it) | Derivati della 1,2,3-tiadiazol-5-il-urea, procedimento per preparare questi composti nonche' mezzi con effetto regolatore della crescita e defogliante che li contengono. | |
IT7822120A0 (it) | Derivati della 1, 2,3-tiadiazolin-2-ide, procedimento per la preparazione di questi composti nonche' mezzi che licontengono con azione regolatrice della crescita per piante. | |
ES8203380A1 (es) | Un procedimiento de preparacion de 4-(1-piperazinil)-fu- ro(3,2-c)piridinas | |
JPS5415808A (en) | Culture soil for growing plant | |
JPS5251394A (en) | Preparation of 6-n-substituted-aminopurines | |
JPS51139688A (en) | Process for preparing new alkaloid tm-64 substance by fermentation | |
JPS5276436A (en) | Insecticide for agricultural and gardening use and method of making th e same | |
JPS53101308A (en) | Derivative of 5,6-dihydro-2h-pyran and its preparation | |
JPS5250812A (en) | Preparation of artificial hiling soil for growing young plant | |
JPS5411296A (en) | Preparation of uricase by fermentation | |
ES8405781A1 (es) | Metodo de obtencion de derivados n-metilcarbamaticos utiles para insecticidas. | |
SU1220307A1 (ru) | Гидробромид 6-карбокси-4,5,6,7-тетрагидроимидазо(4,5-с)пиридина, проявляющий свойства ингибитора синаптосомального захвата гамма-аминомасляной кислоты | |
UA8375A1 (uk) | Спосіб боротьби з бур'янами | |
FR2406636A1 (fr) | Procede de preparation de 2,5-dialkyl-4-hydroxy-2,3-dihydrofuran-3-ones | |
JPS53142591A (en) | Culturing of plant tissue |